Covid-19 Oxford Study
- All
- News
- Videos
-
"Critical Flaws In Methodology": Centre Slams Study On Excess Covid Deaths
Calling it a "gross and misleading overestimate", the centre on Saturday refuted claims of excess mortality during the Covid-19 pandemic in India, as stated in a study led by Indian-origin researchers from Oxford University.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
-
Covid Caused Biggest Drop In Life Expectancy Since World War II: UK Study
The COVID-19 pandemic led to biggest decrease in life expectancy since the World War II, and wiped out years of progress on mortality, according to a study published on Monday by the University of Oxford.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
"Critical Flaws In Methodology": Centre Slams Study On Excess Covid Deaths
Calling it a "gross and misleading overestimate", the centre on Saturday refuted claims of excess mortality during the Covid-19 pandemic in India, as stated in a study led by Indian-origin researchers from Oxford University.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
-
Covid Caused Biggest Drop In Life Expectancy Since World War II: UK Study
The COVID-19 pandemic led to biggest decrease in life expectancy since the World War II, and wiped out years of progress on mortality, according to a study published on Monday by the University of Oxford.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Pfizer Jab Effectiveness "Declines Faster" Than AstraZeneca: Oxford Study
The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
Astra Jab Followed By Pfizer, 4 Weeks Apart, Gives Strong Immunity: Study
Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University of Oxford study, a finding that could enable greater flexibility in the use of scarce supplies.
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
